Literature DB >> 26216733

Initial Clinical Status and Spot Sign Are Associated with Intraoperative Aneurysm Rupture in Patients Undergoing Surgical Clipping for Aneurysmal Subarachnoid Hemorrhage.

Jan-Karl Burkhardt1, Marian Christoph Neidert1, Malte Mohme1, Burkhardt Seifert2, Luca Regli1, Oliver Bozinov1.   

Abstract

OBJECTIVE: To assess clinical and radiographic risk factors for intraoperative aneurysm rupture (ioAR) during surgical clipping after aneurysmal subarachnoid hemorrhage (aSAH) and to analyze its influence on patient outcome.
METHODS: Patient selection was based on a retrospective analysis of our prospective subarachnoid hemorrhage patient database including consecutive patients between January 2008 and August 2012 with aSAH undergoing microsurgical clipping. Demographic data, cardiovascular risk factors, preoperative radiologic aneurysm characteristics, as well as timing of surgery and preoperative severity grades (Hunt and Hess [HH], Fisher, World Federation of Neurological Societies [WFNS]), were collected from hospital charts and surgery videos and compared between patients with and without ioAR.
RESULTS: Of 100 patients (38 men, 62 women) with a median age of 57.4 years (range: 23-85 years), ioAR occurred in 34 cases (34%). Univariate analyses showed that severity grades were significantly higher in the ioAR group (Fisher p = 0.012; HH p = 0.002; WFNS p = 0.023). IoAR was significantly associated with intracerebral hemorrhage (ICH) (23% versus 47%; p = 0.013) and the spot sign as an indicator of active bleeding within the ICH (0% vs 44%; p = 0.007). Multivariate analysis showed that HH was the only significant predictor of ioAR (p = 0.03; odds ratio: 2.3; 95% confidence interval, 1.1-5.0). With a mean follow-up of 17.6 months ( ± 16.6), Glasgow Outcome Scale score, mortality rate (12% versus 15%; p = 0.82), delayed cerebral ischemia (36% versus 38%; p = 0.51), and shunt dependency (32% versus 44%; p = 0.23) were comparable between the non-ioAR and ioAR group.
CONCLUSIONS: Initial clinical status and spot sign were associated with ioAR during microsurgical clipping of ruptured aneurysms. However, there was no difference regarding clinical outcome and complications of the two groups. Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Year:  2015        PMID: 26216733     DOI: 10.1055/s-0035-1558414

Source DB:  PubMed          Journal:  J Neurol Surg A Cent Eur Neurosurg        ISSN: 2193-6315            Impact factor:   1.268


  4 in total

1.  Phantom-based standardization of CT angiography images for spot sign detection.

Authors:  Andrea Morotti; Javier M Romero; Michael J Jessel; Andrew M Hernandez; Anastasia Vashkevich; Kristin Schwab; Joseph D Burns; Qaisar A Shah; Thomas A Bergman; M Fareed K Suri; Mustapha Ezzeddine; Jawad F Kirmani; Sachin Agarwal; Angela Hays Shapshak; Steven R Messe; Chitra Venkatasubramanian; Katherine Palmieri; Christopher Lewandowski; Tiffany R Chang; Ira Chang; David Z Rose; Wade Smith; Chung Y Hsu; Chun-Lin Liu; Li-Ming Lien; Chen-Yu Hsiao; Toru Iwama; Mohammad Rauf Afzal; Christy Cassarly; Steven M Greenberg; Renee' Hebert Martin; Adnan I Qureshi; Jonathan Rosand; John M Boone; Joshua N Goldstein
Journal:  Neuroradiology       Date:  2017-07-20       Impact factor: 2.804

2.  The Morphological and Hemodynamic Characteristics of the Intraoperative Ruptured Aneurysm.

Authors:  Qingyuan Liu; Pengjun Jiang; Jun Wu; Bin Gao; Shuo Wang
Journal:  Front Neurosci       Date:  2019-03-26       Impact factor: 4.677

3.  Adverse intraoperative events during surgical repair of ruptured cerebral aneurysms: a systematic review.

Authors:  William R Muirhead; Patrick J Grover; Ahmed K Toma; Danail Stoyanov; Hani J Marcus; Mary Murphy
Journal:  Neurosurg Rev       Date:  2020-06-16       Impact factor: 3.042

4.  3D printing of intracranial aneurysm based on intracranial digital subtraction angiography and its clinical application.

Authors:  Jian-Li Wang; Zi-Gang Yuan; Guo-Liang Qian; Wu-Qiao Bao; Guo-Liang Jin
Journal:  Medicine (Baltimore)       Date:  2018-06       Impact factor: 1.889

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.